Eugene Joseph Lucas

Eugene Lucas practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Eugene Lucas' NPI, 1659735439, was assigned on April 7, 2016. Eugene Lucas graduated from Drexel University College Of Medicine in 2015. Eugene Lucas holds New York license 300679.

Eugene Lucas' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Eugene Lucas' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Eugene Lucas to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eugene Lucas practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Eugene Lucas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Eugene Lucas is board certified in internal medicine by the American Board of Internal Medicine. Eugene Lucas is licensed in New York.

Dmand AI lists atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic kidney disease, coronary artery disease, diabetic emergency, enlarged thyroid and fluid and electrolyte imbalances among the conditions Eugene Lucas treats.

CMS data shows 424 Medicare services from Eugene Lucas across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $33,781 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Eugene Lucas in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Eugene Lucas' median patient age at 49, with 68% women.

In 2024, Eugene Lucas wrote 396 Medicare Part D claims for 77 patients. 15% of them were for generic drugs. CMS names the drug for 337 of them, across 4 drugs with 11 or more claims each, at $358,799 in total drug cost. In 2023, CMS named 247 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Eugene Lucas for performance year 2024, reported through an alternative payment model (APM). Eugene Lucas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Eugene Lucas as offering telehealth.

Dmand AI links 8 papers to Eugene Lucas, published from 2019 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Documentation, Electronic Health Records and Workflow. Eugene Lucas' most frequent co-authors are Louis Joseph Aronne, MD, Jonathan Edmond Elias, MD and Thomas G. Mcginn, MD.

CMS Open Payments shows 16 general payments to Eugene Lucas from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $256.

Eugene Lucas graduated from Drexel University College Of Medicine in 2015.

Eugene Lucas is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.